Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Allogene
Biotech
Allogene parks Notch CARs, leaving one on the road
Allogene has dropped the bulk of a cell therapy collaboration with Notch Therapeutics, leaving just one chimeric antigen receptor (CAR) target.
Annalee Armstrong
Jan 31, 2024 10:35am
Allogene stops pivotal trials, pursues first-line CAR-T cures
Jan 5, 2024 8:55am
Illumina nets new CEO—Chutes & Ladders
Sep 8, 2023 9:30am
Cell therapy biotech notches down workforce, closes lab
Aug 29, 2023 4:55pm
New year, new C-suite execs—Chutes & Ladders
Jan 6, 2023 9:30am
In a first, Allogene starts pivotal off-the-shelf CAR-T trial
Oct 7, 2022 6:00am